NasdaqCM - Nasdaq Real Time Price USD
Inhibikase Therapeutics, Inc. (IKT)
2.0050
+0.0550
+(2.82%)
At close: June 10 at 4:00:01 PM EDT
2.0489
+0.04
+(2.19%)
After hours: June 10 at 4:01:45 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BELLINI ROBERTO Director | Purchase | Oct 21, 2024 | -- |
| KUSH ARVIND Director | Purchase | Oct 21, 2024 | 145,000 |
| MUNSHI AMIT D Director | Purchase | Oct 21, 2024 | -- |
Related Tickers
SYRE Spyre Therapeutics, Inc.
18.56
+8.16%
PHVS Pharvaris N.V.
18.12
+0.50%
DBVT DBV Technologies S.A.
9.00
+3.69%
DSGN Design Therapeutics, Inc.
4.0100
+2.56%
CLYM Climb Bio Inc
1.3700
+2.24%
AVIR Atea Pharmaceuticals, Inc.
3.2200
+0.31%
AKTX Akari Therapeutics, Plc
1.2750
+2.00%
ACXP Acurx Pharmaceuticals, Inc.
0.3535
+5.55%
CELC Celcuity Inc.
12.92
+0.08%
VRDN Viridian Therapeutics, Inc.
15.42
+3.77%